Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-66,500
Closed -$1.41M 239
2019
Q4
$1.41M Buy
+66,500
New +$1.48M 0.1% 167
2018
Q4
Sell
-110,000
Closed -$4.32M 236
2018
Q3
$4.32M Hold
110,000
0.3% 106
2018
Q2
$5.41M Buy
+110,000
New +$6.24M 0.28% 114

Other funds holding ADNT

J. Goldman & Co's ADNT Position: Q1 2020 in Review

J. Goldman & Co sold out of Adient (ADNT) in Q1 2020, closing a stake of 26,903 shares — an estimated $572K sold.

J. Goldman & Co first reported a position in ADNT in Q4 2016 and held it in 4 quarters. The position peaked at $4.06M in Q4 2016. 284 funds tracked by Wall St. Rank hold ADNT as of Q1 2020.

  • J. Goldman & Co reported no remaining Adient position as of Q1 2020 after selling out during the quarter.
  • J. Goldman & Co sold 26,903 Adient shares in Q1 2020, an estimated $572K.
  • J. Goldman & Co first reported a position in Adient in Q4 2016 and held it in 4 quarters.
  • J. Goldman & Co's Adient position peaked at $4.06M in Q4 2016.
  • 284 funds tracked by Wall St. Rank held Adient as of Q1 2020.

Based on J. Goldman & Co's 13F filing for Q1 2020, filed 15 May 2020.